Zilucoplan (Zilbrysq; UCB), a once-daily subcutaneous C5 complement inhibitor, continues to demonstrate sustained clinical value in …
Tag:
Zilucoplan (Zilbrysq; UCB), a once-daily subcutaneous C5 complement inhibitor, continues to demonstrate sustained clinical value in …